Lunit

📍 Seoul, South Korea🗓 Founded 2013👥 60 employees💰 Last funded Dec 2021
Software Development
LinkedIn
Lunit is a leading provider of AI solutions for cancer diagnostics and therapeutics, with a mission to conquer cancer through AI. Our clinically proven AI enables healthcare providers to detect cancer earlier, make more precise treatment decisions, and improve patient outcomes — transforming how cancer is diagnosed and treated. Our technology spans the entire cancer continuum, from risk prediction and screening optimization to early detection and precision oncology. Lunit’s breast and chest imaging AI boosts diagnostic accuracy and efficiency, while our pathology AI is leveraged by leading pharmaceutical companies to drive biomarker discovery and companion diagnostics (CDx) development. Trusted by 10,000+ sites across 65+ countries, Lunit continues to redefine global standards in data-driven cancer care. Learn more about our technology and mission at www.lunit.io/en
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2013
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
South Korea
1
Frequently asked questions
Who invested in Lunit?
Lunit has 1 investors on record on gritt.io and 1 late-stage investors.
When did Lunit last raise funding?
The most recent investment in Lunit recorded on gritt.io was in December 2021.
When was Lunit founded?
Lunit was founded in 2013.
What industry is Lunit in?
Lunit operates in Software Development. Find similar Software Development investors on gritt.io.
Where is Lunit based?
Lunit is headquartered in Seoul, South Korea.